Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma

Ann N Y Acad Sci. 1993 Aug 12:690:120-34. doi: 10.1111/j.1749-6632.1993.tb44002.x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Neoplasm / biosynthesis
  • Antigens, Neoplasm / immunology
  • Cross Reactions
  • Gangliosides / immunology
  • Humans
  • Hypersensitivity, Delayed / immunology
  • Immunotherapy, Active
  • Melanoma / therapy*
  • Neoplasm Metastasis
  • Survival Analysis

Substances

  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Gangliosides